During February 2024, Revvity proudly stands at the forefront of newborn screening, leading the charge in recognizing and addressing rare diseases that impact countless lives around the world.
Rare diseases, often overlooked, affect a significant portion of the global population. Revvity's dedication to newborn screening is a testament to our commitment to early detection and intervention, paving the way for improved outcomes and quality of life.
Gate form
Like what you're reading?
To view the full content, please answer a few questions.
Gated components